Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 14, 2009, Pages 5779-5783

  Makam, Megha ^a   Diaz, Daisy ^a   Laval, Julie ^a   Gernez, Yael ^a   Conrad, Carol K ^a   Dunn, Colleen E ^a   Davies, Zoe A ^a   Moss, Richard B ^a   Herzenberg, Leonore A ^a   Herzenberg, Leonard A ^a   Tirouvanziam, Rabindra ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CFTR; EN RAGE; Flow cytometry; S6 ribosomal protein stromal derived factor 1

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CD39 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GROWTH FACTOR RECEPTOR; INITIATION FACTOR 4E; INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN;

ARTICLE; CYSTIC FIBROSIS; HUMAN; METABOLISM; NEUTROPHIL; PRIORITY JOURNAL;

CHEMOTAXIS, LEUKOCYTE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYSTIC FIBROSIS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LUNG DISEASES; NEUTROPHILS; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN KINASES; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EUKARYOTA; MAMMALIA;

EID: 65249151394     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0813410106     Document Type: Article

References (40)

1. Davis PB (2006) Cystic fibrosis since 1938. Am J Respir Crit Care Med 173:475-482.
2. Tirouvanziam R (2006) Neutrophilic inflammation as a major determinant in the progression of cystic fibrosis. Drug News Perspect 19:609-614.
3. Meyer KC, Zimmerman J (1993) Neutrophil mediators, pseudomonas, and pulmonary dysfunction in cystic fibrosis. J Lab Clin Med 121:654-661.
4. Borregaard N, Sorensen OE, Theilgaard-Monch K (2007) Neutrophil granules: A library of innate immunity proteins. Trends Immunol 28:340-345.
5. McMorran BJ, et al. (2007) Novel neutrophil-derived proteins in bronchoalveolar lavage fluid indicate an exaggerated inflammatory response in pediatric cystic fibrosis patients. Clin Chem 53:1782-1791.
6. Tirouvanziam R, Khazaal I, Peault B (2002) Primary inflammation in human cystic fibrosis small airways. Am J Physiol Lung Cell Mol Physiol 283:L445-L451.
7. Theilgaard-Monch K, Porse BT, Borregaard N (2006) Systems biology of neutrophil differentiation and immune response. Curr Opin Immunol 18:54-60.
8. Foell D, Wittkowski H, Vogl T, Roth J (2007) S100 proteins expressed in phagocytes: A novel group of damage-associated molecular pattern molecules. J Leukocyte Biol 81:28-37.
9. Lotze MT, et al. (2007) The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev 220:60-81.
10. Tirouvanziam R, et al. (2008) Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. Proc Natl Acad Sci USA 105:4335-4339.
11. Lehman N, et al. (2007) Phospholipase D2-derived phosphatidic acid binds to and activates ribosomal p70 S6 kinase independently of mTOR. FASEB J 21:1075-1087.
12. Jastrzebski K, Hannan KM, Tchoubrieva EB, Hannan RD, Pearson RB (2007) Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function. Growth Factors 25:209-226.
13. Mayr B, Montminy M (2001) Transcriptional regulation by the phosphorylationdependent factor CREB. Nat Rev Mol Cell Biol 2:599-609.
14. Thomas SR, Ray A, Hodson ME, Pitt TL (2000) Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax 55:795-797.
15. Deves R, Boyd CA (2000) Surface antigen CD98(4F2): Not a single membrane protein, but a family of proteins with multiple functions. J Membr Biol 173:165-177.
16. Taylor ML, et al. (2000) Extensive surface phenotyping of alveolar macrophages in interstitial lung disease. Clin Immunol 94:33-41.
17. Eyles JL, Roberts AW, Metcalf D, Wicks IP (2006) Granulocyte colony-stimulating factor and neutrophils-forgotten mediators of inflammatory disease. Nat Clin Pract Rheumatol 2:500-510.
18. Huttunen HJ, Kuja-Panula J, Rauvala H (2002) Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation. J Biol Chem 277:38635-38646.
19. Mukherjee TK, Mukhopadhyay S, Hoidal JR (2008) Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology. Respir Physiol Neurobiol 162:210-215.
20. Foell D, et al. (2003) Expression of S100A12 (EN-RAGE) in cystic fibrosis. Thorax 58:613-617.
21. Liao H, Hyman MC, Pinsky DJ (2007) Regulation of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) expression in macrophages by cAMP via PKA/PI3K/CREB (abstract). Circulation 116:92.
22. Pulte ED, et al. (2007) CD39/NTPDase-1 activity and expression in normal leukocytes. Thromb Res 121:309-317.
23. Cristillo AD, et al. (2002) Up-regulation of HIV coreceptor CXCR4 expression in human T lymphocytes is mediated in part by a cAMP-responsive element. FASEB J 16:354-364.
24. Suratt BT, et al. (2004) Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis. Blood 104:565-571.
25. Christopher MJ, Link DC (2007) Regulation of neutrophil homeostasis. Curr Opin Hematol 14:3-8.
26. Voynow JA, Fischer BM, Zheng S (2008) Proteases and cystic fibrosis. Int J Biochem Cell Biol 40:1238-1245.
27. Mager S, Sloan J (2003) Possible role of amino acids, peptides, and sugar transporter in protein removal and innate lung defense. Eur J Pharmacol 479:263-267.
28. Tirouvanziam R, Conrad CK, Bottiglieri T, Herzenberg LA, Moss RB (2006) High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis. Proc Natl Acad Sci USA 103:4628-4633.
29. Wood LG, et al. (2001) Oxidative stress in cystic fibrosis: Dietary and metabolic factors. J Am Coll Nutr 20:157-165.
30. Foell D, et al. (2008) Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. J Pathol 216:183-192.
31. Rowe SM, et al. (2008) Potential role of high-mobility group box 1 in cystic fibrosis airway disease. Am J Respir Crit Care Med 178:822-831.
32. Corriden R, et al. (2008) Ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1/CD39) regulates neutrophil chemotaxis by hydrolyzing released ATP to adenosine. J Biol Chem 283:28480-28486.
33. Esther CR, Jr, et al. (2008) Extracellular purines are biomarkers of neutrophilic airway inflammation. Eur Respir J 31:949-956.
34. Hashimoto I, et al. (2008) Blocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells. Eur J Cancer 44:1022-1029.
35. Petty JM, et al. (2007) Pulmonary stromal-derived factor-1 expression and effect on neutrophil recruitment during acute lung injury. J Immunol 178:8148-8157.
36. Rao RM, et al. (2004) Elastase release by transmigrating neutrophils deactivates endothelial-bound SDF-1alpha and attenuates subsequent T lymphocyte transendothelial migration. J Exp Med 200:713-724.
37. Hunter MG, Druhan LJ, Massullo PR, Avalos BR (2003) Proteolytic cleavage of granulocyte colony-stimulating factor and its receptor by neutrophil elastase induces growth inhibition and decreased cell surface expression of the granulocyte colony-stimulating factor receptor. Am J Hematol 74:149-155.
38. Hartl D, et al. (2007) Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med 13:1423-1430.
39. Belkhadir Y, Subramaniam R, Dangl JL (2004) Plant disease resistance protein signaling: NBS-LRR proteins and their partners. Curr Opin Plant Biol 7:391-399.
40. von Bernuth H, et al. (2008) Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321:691-696.